Recruitment for a survey on the unmet needs of patients living with metastatic colorectal cancer (mCRC): Lessons from a European study

被引：0
|
作者：
Maravic, Z. [1 ]
Trenevski, J. Stanisic [2 ]
Bokros, J. [3 ]
Casado, A. Ruiz [4 ]
de Pedro, C. Gonzalez [5 ]
Otero, M. Mendez [5 ]
Borras, J. [6 ]
Ferro, T. [7 ]
Rial, O. [7 ]
机构：
[1] EuropaColon, Salisbury, Wilts, England
[2] Dom Zdravlja Vozdovac, Belgrade, Serbia
[3] Semmelweis Univ, Budapest, Hungary
[4] Hosp Puerta de Hierro Majadahonda, Majadahonda, Spain
[5] Hosp Puerta de Hierro Majadahonda, Serv Oncol Med, Majadahonda, Madrid, Spain
[6] ICO Hospitalet, Lhospitalet De Llobregat, Spain
[7] Catalan Inst Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 273
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A pilot study examining the unmet needs of cancer survivors living with polypathology
    Siu, M.
    Catton, P.
    Jones, J.
    Jadad, A. R.
    CURRENT ONCOLOGY, 2013, 20 (03) : E266 - E269
  • [42] Liver Only Metastatic Disease in Patients With Metastatic Colorectal Cancer (mCRC), Impact of Surgery and Chemotherapy
    Bishnoi, S.
    Price, T.
    Beeke, C.
    Karapetis, C.
    Townsend, A.
    Maddern, G.
    Padbury, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S403 - S403
  • [43] Exploring Unmet Needs from an Online Metastatic Breast Cancer Support Group: A Qualitative Study
    Kadravello, Aravinthan
    Tan, Seng-Beng
    Ho, Gwo-Fuang
    Kaur, Ranjit
    Yip, Cheng-Har
    MEDICINA-LITHUANIA, 2021, 57 (07):
  • [44] The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)
    Akbulut, H.
    Ocal, M.
    Sonugur, G.
    Akay, B.
    Babahan, C.
    Abgarmi, S. Abdi
    Demirkazik, A.
    Icli, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [46] A complete blood count as a prognostic marker in patients with metastatic colorectal cancer (mCRC)
    Krakowska, M.
    Debska-Szmich, S.
    Czernek, U.
    Czyzykowski, R.
    Potemski, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 9 - 10
  • [47] Tumor burden (TB) as a prognostic indicator in patients with metastatic colorectal cancer (mCRC).
    Loh, Kiley Wei Jen
    Shapiro, Jeremy David
    Tran, Ben
    Wong, Hui-Li
    Wong, Shu Fen
    Richardson, Gary Edward
    Harold, Michael
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [48] EXPLORING UNMET NEEDS FROM AN ONLINE METASTATIC BREAST CANCER SUPPORT GROUP: A QUALITATIVE STUDY
    Kadravello, Aravinthan
    Yip, Cheng-Har
    Tan, Seng Beng
    Ho, Gwo-Fuang
    Singh, Ranjit Kaur Pritam
    BREAST, 2021, 59 : S56 - S56
  • [49] Phase II trial of figitumumab in patients with refractory, metastatic colorectal cancer (mCRC)
    Becerra, C.
    Salazar, R.
    Garcia-Carbonero, R.
    Thomas, A. L.
    Vazquez-Mazon, F.
    Cassidy, J.
    Maughan, T.
    Gallen, M.
    Iveson, T.
    Hixon, M.
    Gualberto, A.
    Yin, D.
    Bergsland, E. K.
    Li, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Skin toxicity in elderly patients with metastatic colorectal cancer (mCRC) treated with Cetuximab
    Jehn, C.
    Stenzel, L.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ONKOLOGIE, 2010, 33 : 175 - 176
12345